Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures

Objective: To evaluate efficacy and tolerability of adjunctive lacosamide in children and adolescents with uncontrolled focal (partial-onset) seizures.
Methods: Double-blind trial (SP0969; NCT01921205) of patients (≥4 to <17 years) with uncontrolled focal seizures, randomized (1:1) to adjunctive lacosamide/placebo. Following 6-week Titration, patients who reached the target dose-range for their weight (<30 kg: 8–12 mg/kg/day oral solution; ≥30 to <50 kg: 6–8 mg/kg/day oral solution; ≥50 kg: 300–400 mg/day tablets) entered a 10-week Maintenance period. Primary outcome was change in focal seizure frequency/28 days from Baseline to Maintenance.
Results: 343 patients were randomized; 306 (lacosamide: 152/171 [88.9%]; placebo: 154/172 [89.5%]) completed Treatment (Titration and Maintenance). Adverse events (AEs) were the most common reasons for discontinuation during Treatment (lacosamide: 4.1%; placebo: 5.8%). From Baseline to Maintenance, percent reduction in focal seizure frequ...